Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Sanofi and REVOLUTION Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers

Thursday, July 19, 2018

Sanofi and REVOLUTION Medicines Inc today announced an exclusive worldwide partnership to develop and commercialize targeted therapies based on the biology of the cellular enzyme SHP2 for patients with nonsmall lung cancer and other types of cancer carrying certain mutations This collaboration build..

PolyU - Axis Therapeutics Joint Center for Immunotherapy Launched to Develop Innovative Cancer Treatments

Thursday, July 19, 2018

The Hong Kong Polytechnic University PolyU will join forces with Axis Therapeutics a newly established joint venture by two global biopharmaceutical companies Athenex Inc and Xiangxue Pharmaceutical to foster the research and development of translational medicine by setting up a Joint Center for Im..

RDD Pharma Announces IND Clearance to Advance RDD-0315 to Treat Fecal Incontinence in Patients with Spinal Cord Injury

Wednesday, July 18, 2018

RDD Pharma a specialty pharmaceutical company focused on the development of innovative therapies for anorectal and gastrointestinal disorders announced today that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application The IND was filed in the US on May 30 20..

Advanced Proteome Therapeutics Announces Collaboration with Noria Pharmaceuticals

Wednesday, July 18, 2018

Advanced Proteome Therapeutics Corporation is pleased to announce the collaboration of APC with Noria Pharmaceuticals Inc in the rapidly growing field of antibody radioisotope conjugates APC will test its proprietary siteselective linker technology with Norias proprietary MacroPA radioisotope che..

Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients

Tuesday, July 17, 2018

Nohla Therapeutics a leading developer of universal offtheshelf cell therapies for patients with hematologic malignancies and other critical diseases today announced that the US Food and Drug Administration FDA has granted Nohlas lead product candidate dilanubicel NLA101 Orphan Drug Designation for ..

Edge Pharmacy Services Bringing New Unit-Dose Pharmaceutical Products to Canada Through Acquisition of Apolab

Tuesday, July 17, 2018

Edge Pharmacy Services LLC is excited to announce that it has acquired Apolab ULC of Mississauga Ontario Edge is a rapidly growing US based 503B Outsourcing facility with business elements spanning the gamut of compounded pharmaceutical products With the acquisition of the Apolab facility Edge moves..

FDA approves the first drug with an indication for treatment of smallpox

Monday, July 16, 2018

The US Food and Drug Administration today approved TPOXX tecovirimat the first drug with an indication for treatment of smallpox Though the World Health Organization declared smallpox a contagious and sometimes fatal infectious disease eradicated in 1980 there have been longstanding concerns that sm..

Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial

Friday, July 13, 2018

Sirona Biochem Corp announced today that partner Jiangsu Wanbang Biopharmaceuticals Wanbang has confirmed the Investigational New Drug IND submission to Chinas Food and Drug Administration CFDA for its SGLT2 inhibitor was approved for clinical trial Wanbang will be entering a Phase I clinical trial ..

Otsuka Pharmaceutical to Acquire Visterra

Thursday, July 12, 2018

Otsuka Pharmaceutical Co Ltd and Visterra Inc announce that they have entered into a definitive merger agreement pursuant to which Otsuka will acquire Visterra for approximately USD 430 million in an allcash transaction The Otsuka and Visterra boards of directors have approved the transaction Subjec..

Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd

Thursday, July 12, 2018

CURE Pharmaceutical an innovative drug delivery and development company announced today that it has signed a term sheet with Therapix Biosciences Ltd a specialty clinicalstage pharmaceutical company developing cannabinoidbased treatments to acquire the nonpain assets of Therapix subject to the compl..